{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T20:15:31Z","timestamp":1767212131774,"version":"build-2065373602"},"reference-count":35,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T00:00:00Z","timestamp":1660608000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Catalan Society of digestive diseases (Societat Catalana de Digestologia)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Chronic liver disease results in a low response rate to the hepatitis B virus vaccine. Information on the efficacy of the double adjuvanted vaccine FENDRIX\u00ae (3-O-desacyl-4\u2019-monophosphoryl lipid A and aluminum phosphate) and single adjuvant HBVAXPRO\u00ae40 (aluminum hydroxyphosphate sulfate) in chronic liver disease is scarce. The primary aim of this prospective study in clinical practice was to evaluate the effectiveness of HBVAXPRO\u00ae40 and FENDRIX\u00ae in this setting. Patients received HBVAXPRO\u00ae (0, 1 and 6 months) or FENDRIX\u00ae (0, 1, 2 and 6 months) depending on availability. Clinical data and anti-HBs levels were collected at 2, 6 and 12 months. A total of 125 patients were included (mean age 61.8 years; 57.6% males; 43.2% liver cirrhosis; 75.9% Child A and 24.1% Child B): 76 were vaccinated with HBVAXPRO\u00ae and 49 with FENDRIX\u00ae. There were no significant differences between the two vaccines. The overall response rates at 2, 6 and 12 months were 76.8, 72.8 and 59.2%, respectively. In the univariate analysis, active alcohol intake, alcohol etiology, liver cirrhosis and ultrasound signs of portal hypertension were associated with a lower response to vaccination, whereas in the multivariate analysis, liver cirrhosis was the only factor that significantly increased the likelihood of nonresponse (OR 10.5). HBVAXPRO\u00ae and FENDRIX\u00ae are good options for HBV vaccination in patients with chronic liver disease.<\/jats:p>","DOI":"10.3390\/vaccines10081323","type":"journal-article","created":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T03:15:27Z","timestamp":1660706127000},"page":"1323","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy of Hepatitis B Virus Vaccines HBVaxpro40\u00a9 and Fendrix\u00a9 in Patients with Chronic Liver Disease in Clinical Practice"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3675-1135","authenticated-orcid":false,"given":"Diana","family":"Horta","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Hospital Universitari M\u00fatua Terrassa, Universitat de Barcelona, 08221 Terrassa, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, 28029 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Montserrat","family":"Forn\u00e9","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Hospital Universitari M\u00fatua Terrassa, Universitat de Barcelona, 08221 Terrassa, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Agust\u00ed","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Hospital Universitari M\u00fatua Terrassa, Universitat de Barcelona, 08221 Terrassa, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnes","family":"Raga","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Hospital Universitari M\u00fatua Terrassa, Universitat de Barcelona, 08221 Terrassa, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7090-0106","authenticated-orcid":false,"given":"Albert","family":"Mart\u00edn-Cardona","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Hospital Universitari M\u00fatua Terrassa, Universitat de Barcelona, 08221 Terrassa, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, 28029 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juana Mar\u00eda","family":"Hern\u00e1ndez-Soto","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Hospital Universitari M\u00fatua Terrassa, Universitat de Barcelona, 08221 Terrassa, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Ruiz-Ram\u00edrez","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Hospital Universitari M\u00fatua Terrassa, Universitat de Barcelona, 08221 Terrassa, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Esteve-Comas","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Hospital Universitari M\u00fatua Terrassa, Universitat de Barcelona, 08221 Terrassa, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, 28029 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,8,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.cgh.2011.02.031","article-title":"Immune Dysfunction and Infections in Patients With Cirrhosis","volume":"9","author":"Bonnel","year":"2011","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.gastrohep.2009.03.009","article-title":"Eficacia y seguridad de la vacunaci\u00f3n para la hepatitis A y la hepatitis B en pacientes con hepatopat\u00eda cr\u00f3nica","volume":"32","author":"Varasa","year":"2009","journal-title":"Gastroenterol. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/hep.24024","article-title":"Meeting vaccination quality measures for hepatitis A and B virus in patients with chronic hepatitis C infection","volume":"53","author":"Kramer","year":"2010","journal-title":"Hepatology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1572-0241.2007.01609.x","article-title":"Incidence of HAV and HBV Infections and Vaccination Rates in Patients With Autoimmune Liver Diseases","volume":"103","author":"Teufel","year":"2008","journal-title":"Am. J. Gastroenterol."},{"key":"ref_5","first-page":"120","article-title":"Vaccinating patients with chronic liver disease","volume":"8","author":"Alter","year":"2012","journal-title":"Gastroenterol. Hepatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1056\/NEJMcp041507","article-title":"Prevention of Hepatitis B with the Hepatitis B Vaccine","volume":"351","author":"Poland","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_7","first-page":"CD008256","article-title":"Booster dose vaccination for preventing hepatitis B","volume":"2016","author":"Poorolajal","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"(2019). World Health Organization Hepatitis B vaccines: WHO position paper, July 2017\u2014Recommendations. Vaccine, 37, 223\u2013225.","DOI":"10.1016\/j.vaccine.2017.07.046"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/00042737-200104000-00010","article-title":"Immunogenicity of two accelerated hepatitis B vaccination protocols in liver transplant candidates","volume":"13","author":"Engler","year":"2001","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1046\/j.1365-2893.2001.00301.x","article-title":"Increased effective immunogenicity to high-dose and short-interval hepatitis B virus vaccination in individuals with chronic hepatitis without cirrhosis","volume":"8","author":"Idilman","year":"2001","journal-title":"J. Viral Hepat."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/00042737-200104000-00009","article-title":"Hepatitis B vaccination in liver transplant candidates","volume":"13","author":"Castells","year":"2001","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_12","first-page":"217","article-title":"Impaired antibody response rates after high dose short interval hepatitis B virus vaccination of immunosuppressed individuals","volume":"50","author":"Idilman","year":"2003","journal-title":"Hepatogastroenterology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1016\/j.vaccine.2004.11.057","article-title":"Randomized trial of recombinant hepatitis B vaccine in HIV-infected adult patients comparing a standard dose to a double dose","volume":"23","author":"Fonseca","year":"2005","journal-title":"Vaccine"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1111\/j.1365-2036.2012.05110.x","article-title":"Comparison of the effectiveness of two protocols for vaccination (standard and double dosage) against hepatitis B virus in patients with inflammatory bowel disease","volume":"35","author":"Gisbert","year":"2012","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_15","first-page":"1590","article-title":"Failure of hepatitis B immunization in liver transplant recipients: Results of a prospective trial","volume":"85","author":"Carey","year":"1990","journal-title":"Am. J. Gastroenterol."},{"key":"ref_16","first-page":"1245","article-title":"Response to hepatitis B vaccination by liver transplant candidates","volume":"37","author":"Love","year":"1992","journal-title":"Am. J. Dig. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0002-9629(15)40643-3","article-title":"Vaccination against Hepatitis B in Patients with Chronic Liver Disease Awaiting Liver Transplantation","volume":"318","author":"Horlander","year":"1999","journal-title":"Am. J. Med Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1572-0241.2002.05482.x","article-title":"The effect of high dose and short interval HBV vaccination in individuals with chronic hepatitis C","volume":"97","author":"Idilman","year":"2002","journal-title":"Am. J. Gastroenterol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/jvh.13509","article-title":"Efficacy of an accelerated double-dose hepatitis B vaccine regimen in patients with cirrhosis","volume":"28","author":"Pocurull","year":"2021","journal-title":"J. Viral Hepat."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/lt.20836","article-title":"Immunogenicity and safety of an experimental adjuvanted hepatitis B candidate vaccine in liver transplant patients","volume":"12","author":"Nevens","year":"2006","journal-title":"Liver Transplant."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1590\/S1413-86702008000400009","article-title":"Double-dose hepatitis B vaccination in cirrhotic patients on a liver transplant waiting list","volume":"12","author":"Bonazzi","year":"2008","journal-title":"Braz. J. Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1053\/jlts.2001.23069","article-title":"Double-dose accelerated hepatitis B vaccine in patients with end-stage liver disease","volume":"7","author":"Arslan","year":"2001","journal-title":"Liver Transplant."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2893.2005.00674.x","article-title":"Efficacy of repeated high-dose hepatitis B vaccine (80 mug) in patients with chronic liver disease","volume":"13","author":"Aziz","year":"2005","journal-title":"J. Viral Hepat."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis\u20142021 update","volume":"75","author":"Berzigotti","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.transproceed.2012.05.071","article-title":"Response to Vaccination Against Hepatitis B Virus with a Schedule of Four 40-\u03bcg Doses in Cirrhotic Patients Evaluated for Liver Transplantation: Factors Associated with a Response","volume":"44","author":"Domingo","year":"2012","journal-title":"Transplant. Proc."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3748\/wjg.v13.i2.294","article-title":"Immunogenicity of recombinant hepatitis B virus vaccine in patients with and without chronic hepatitis C virus infection: A case-control study","volume":"13","author":"Daryani","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1016\/S0264-410X(03)00221-4","article-title":"Intramuscular versus intradermal administration of anti-hepatitis B vaccine in non-cirrhotic hepatitis C patients","volume":"21","author":"Arbizu","year":"2003","journal-title":"Vaccine"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/hep.510310134","article-title":"Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C","volume":"31","author":"Wiedmann","year":"2000","journal-title":"Hepatology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"27251","DOI":"10.1038\/srep27251","article-title":"Factors influencing immunologic response to hepatitis B vaccine in adults","volume":"6","author":"Yang","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.pnpbp.2015.09.001","article-title":"Opposing effects of alcohol on the immune system","volume":"65","author":"Barr","year":"2015","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1574-695X.1999.tb01397.x","article-title":"Immune dysfunction in patients with diabetes mellitus (DM)","volume":"26","author":"Geerlings","year":"1999","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1365-2036.2004.01906.x","article-title":"Hepatitis vaccination in patients with chronic liver disease","volume":"19","author":"Reiss","year":"2004","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/MIB.0b013e31827febe9","article-title":"Kinetics of Anti\u2013Hepatitis B Surface Antigen Titers After Hepatitis B Vaccination in Patients With Inflammatory Bowel Disease","volume":"19","author":"Gisbert","year":"2013","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/cid\/cit816","article-title":"Executive Summary: 2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host","volume":"58","author":"Rubin","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1086\/589722","article-title":"Excellent Response Rate to a Double Dose of the Combined Hepatitis A and B Vaccine in Previous Nonresponders to Hepatitis B Vaccine","volume":"198","author":"Cardell","year":"2008","journal-title":"J. Infect. Dis."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/10\/8\/1323\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:09:17Z","timestamp":1760141357000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/10\/8\/1323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,16]]},"references-count":35,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,8]]}},"alternative-id":["vaccines10081323"],"URL":"https:\/\/doi.org\/10.3390\/vaccines10081323","relation":{},"ISSN":["2076-393X"],"issn-type":[{"type":"electronic","value":"2076-393X"}],"subject":[],"published":{"date-parts":[[2022,8,16]]}}}